To conclude, our data identifies the miR-98-5p/PPP1R15B axis as a significant regulator of hepatic gluconeogenesis and lipogenesis and offers a possible path to explore the therapeutic potential of this axis to target deregulated hepatic metabolism during metabolic diseases. The gene discussed is PPP1R15B; the disease is metabolic disease.